Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Medicinova Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +6 vs. Q3 2022
- Shares held
- 6.21M
- −636.2K (−9.3%) vs. Q3 2022
- Total value
- $12.7M
- −$2.13M (−14.3%) vs. Q3 2022
- New holders
- 10
- 9 more added
- Sold out
- 4
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $2.27M | 1.26% | 00.0% | Unchanged |
| BlackRock Inc. | 711,782 | $1.46M | 0.00% | +1,127+0.2% | Added |
| Vanguard Group Inc | 625,831 | $1.28M | 0.00% | −1,201,901−65.8% | Reduced |
| Citigroup Inc | 447,957 | $918.3K | 0.00% | −2,265−0.5% | Reduced |
| Geode Capital Management, LLC | 437,247 | $896.0K | 0.00% | +4,374+1.0% | Added |
| Jane Street Group, LLC | 267,824 | $549.0K | 0.00% | +267,824 | New |
| Millennium Management LLC | 251,626 | $516.0K | 0.00% | −101,330−28.7% | Reduced |
| JPMorgan Chase & Co | 249,345 | $511.0K | 0.00% | −48,731−16.3% | Reduced |
| Bridgeway Capital Management, LLC | 195,147 | $400.1K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 179,202 | $367.0K | 0.01% | +179,202 | New |
| Bank of America Corp | 177,259 | $363.4K | 0.00% | +22,508+14.5% | Added |
| Northern Trust Corp | 162,227 | $332.6K | 0.00% | −596−0.4% | Reduced |
| UBS Group AG | 154,474 | $316.7K | 0.00% | −29,554−16.1% | Reduced |
| Barclays PLC | 148,400 | $304.2K | 0.00% | −9,900−6.3% | Reduced |
| Renaissance Technologies LLC | 142,300 | $292.0K | 0.00% | −7,500−5.0% | Reduced |
| State Street Corp | 142,298 | $291.7K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 120,200 | $246.4K | 0.00% | −480.0% | Reduced |
| Ergoteles LLC | 110,996 | $227.5K | 0.01% | +110,996 | New |
| Dimensional Fund Advisors LP | 75,005 | $153.0K | 0.00% | +28,906+62.7% | Added |
| Capricorn Fund Managers Ltd | 66,716 | $137.0K | 0.04% | +66,716 | New |
| Susquehanna International Group, LLP | 64,356 | $131.9K | 0.00% | −48,757−43.1% | Reduced |
| Goldman Sachs Group Inc | 51,019 | $104.6K | 0.00% | +51,019 | New |
| Schonfeld Strategic Advisors LLC | 44,500 | $91.2K | 0.00% | −900−2.0% | Reduced |
| Citadel Advisors LLC | 41,237 | $84.5K | 0.00% | +16,710+68.1% | Added |
| Tower Research Capital LLC (TRC) | 36,158 | $74.0K | 0.00% | +31,801+729.9% | Added |
| Virtu Financial LLC | 25,674 | $53.0K | 0.01% | +25,674 | New |
| ExodusPoint Capital Management, LP | 23,184 | $48.0K | 0.00% | +23,184 | New |
| Morgan Stanley | 22,520 | $46.2K | 0.00% | +10,852+93.0% | Added |
| Price T Rowe Associates Inc | 20,700 | $42.0K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $39.0K | 0.00% | +300+1.6% | Added |
| Squarepoint Ops LLC | 18,744 | $38.4K | 0.00% | +18,744 | New |
| Charles Schwab Investment Management Inc | 17,843 | $36.6K | 0.00% | 00.0% | Unchanged |
| Blankinship & Foster, LLC | 15,700 | $32.2K | 0.01% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 12,500 | $25.6K | 0.01% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10,528 | $21.6K | 0.00% | +10,528 | New |
| Qube Research & Technologies Ltd | 10,440 | $21.4K | 0.00% | −24,626−70.2% | Reduced |
| Cutler Group LP | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 412 | $845 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 334 | $685 | 0.00% | +8+2.5% | Added |
| Northwestern Mutual Wealth Management Co | 305 | $625 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 8 | $0 | 0.00% | +8 | New |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |